Publications by authors named "Pablo Parker"

Claim this Profile
L
Long-Term Follow-Up of Multiple Myeloma Patients Treated with Tandem Autologous Transplantation Following Melphalan and Upon Recovery, Total Marrow Irradiation.
Colton Ladbury, George Somlo, Andy Dagis, Dongyun Yang, Saro Armenian, Pablo Parker

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch.
Monzr M Al Malki, Ketevan Gendzekhadze, Dongyun Yang, Sally Mokhtari, Pablo Parker

Transplantation· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantation.
Monzr M Al Malki, Ketevan Gendzekhadze, Tracey Stiller, Sally Mokhtari, Chatchada Karanes, Pablo Parker

Bone Marrow Transplant· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.
Badri Modi, Michael Hernandez-Henderson, Dongyun Yang, Jeremy Klein, Sanjeet Dadwal, Pablo Parker

Biol Blood Marrow Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Monzr M Al Malki, Nitya Nathwani, Dongyun Yang, Saro Armenian, Sanjeet Dadwal, Pablo Parker

Biol Blood Marrow Transplant· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.
Anthony Stein, Joycelynne Palmer, Ni-Chun Tsai, Monzr M Al Malki, Ibrahim Aldoss, Pablo Parker

Biol Blood Marrow Transplant· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graft-versus-Host Disease.
Christos Theophanous, John A Irvine, Pablo Parker, Gloria B Chiu

Biol Blood Marrow Transplant· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease.
Efrem Gebremedhin, Carolyn E Behrendt, Ryotaro Nakamura, Pablo Parker, Behrouz Salehian

Inflammation· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.
Sepideh Shayani, Joycelynne Palmer, Tracey Stiller, Xueli Liu, Sandra H Thomas, Pablo M Parker

Biol Blood Marrow Transplant· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain imaging findings in symptomatic patients after allogeneic haematopoietic stem cell transplantation: correlation with clinical outcome.
Bihong T Chen, A Orlando Ortiz, Andrew Dagis, Cheryl Torricelli, Pablo Parker

Eur Radiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis.
Ryotaro Nakamura, Joycelynne M Palmer, Margaret R O'Donnell, Tracey Stiller, Sandra H Thomas, Pablo M Parker

Leuk Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
Firoozeh Sahebi, Paul H Frankel, Len Farol, Amrita Y Krishnan, Ji-lian Cai, Pablo M Parker

Biol Blood Marrow Transplant· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma.
George Somlo, Ricardo Spielberger, Paul Frankel, Chatchada Karanes, Amrita Krishnan, Pablo Parker

Clin Cancer Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
Roberto Rodriguez, Ryotaro Nakamura, Joycelynne M Palmer, Pablo Parker, Sepideh Shayani

Blood· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.
Stephanie Campbell, Can-Lan Sun, Seira Kurian, Liton Francisco, Andrea Carter, Pablo Parker

Cancer· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates.
Ryotaro Nakamura, Nademanee Auayporn, David D Smith, Joycelynne Palmer, Joel Y Sun, Pablo Parker

Biol Blood Marrow Transplant· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.
Kikuchi Takahide, Pablo M Parker, Michael Wu, William Y K Hwang, Paul A Carpenter

Biol Blood Marrow Transplant· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.
Sergio Giralt, Brent Logan, Douglas Rizzo, Mei-Jie Zhang, Karen Ballen, Pablo Parker

Biol Blood Marrow Transplant· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients.
Joel Y Sun, Andrew Dagis, Laima Gaidulis, Marcia M Miller, Roberto Rodriguez, Pablo Parker

Biol Blood Marrow Transplant· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
Christopher J Fraser, Smita Bhatia, Kirsten Ness, Andrea Carter, Liton Francisco, Pablo Parker

Blood· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.
Auayporn Nademanee, Stephen Forman, Arturo Molina, Henry Fung, David Smith, Pablo Parker

Blood· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Richard A Nash, Laura Johnston, Pablo Parker, Jeannine S McCune, Barry Storer

Biol Blood Marrow Transplant· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
Paul A Carpenter, James Lowder, Laura Johnston, Haydar Frangoul, Hanna Khoury, Pablo Parker

Biol Blood Marrow Transplant· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.
Francisco Lopez, Pablo Parker, Auayporn Nademanee, Roberto Rodriguez, Zaid Al-Kadhimi

Biol Blood Marrow Transplant· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.
Anthony S Stein, Margaret R O'Donnell, Marilyn L Slovak, David S Snyder, Auayporn P Nademanee, Pablo Parker

J Clin Oncol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis